SCHEMBL5198345

SCHEMBL5198345

COC(=O)Oc1cc(C)c2cc(Br)ccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.54
CASP3 P42574 2/20 0.46
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 2/20 0.45
GAA P10253 2/20 0.45
HTT P42858 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
RXFP1 Q9HBX9 4/20 0.43
PRNP P04156 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PPARG P37231 1/20 0.41
NR2E3 Q9Y5X4 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
POLB P06746 1/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
KMT2A Q03164 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1224169 0.81 L3MBTL1 (0.60) L3MBTL1CASP3ALDH1A1KDM4EGAA
SCHEMBL4483729 0.77 ALDH1A1 (0.58) L3MBTL1CASP3ALDH1A1KDM4EGAA
SCHEMBL7609731 0.77 HSD17B10 (0.42) L3MBTL1CASP3ALDH1A1KDM4EGAA
SCHEMBL6654938 0.75 ALDH1A1 (0.47) L3MBTL1CASP3ALDH1A1KDM4EGAA
SCHEMBL28121717 0.73 ALDH1A1 (0.54) L3MBTL1CASP3ALDH1A1KDM4EGAA
SCHEMBL12144951 0.71 ALDH1A1 (0.42) L3MBTL1CASP3ALDH1A1KDM4EGAA
SCHEMBL12909980 0.70 NUDT1 (0.43) L3MBTL1CASP3ALDH1A1KDM4EGAA
SCHEMBL15724648 0.70 CYP1A2 (0.57) CASP3ALDH1A1KDM4EGAAHTT
SCHEMBL30048942 0.70 CYP1A2 (0.57) CASP3ALDH1A1KDM4EGAAHTT
SCHEMBL1999627 0.69 ALDH1A1 (0.78) L3MBTL1ALDH1A1KDM4EGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737823-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2007-01-03 EP disclosed
WO-2005103002-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO disclosed